Core Viewpoint - The Dutch government's decision to freeze the global operations of Nexperia, a subsidiary of Wentech Technology, is criticized as an excessive intervention based on geopolitical bias rather than factual risk assessment, violating EU principles of market economy and fair competition [1][3]. Group 1: Company Position - Wentech Technology firmly opposes the politicization of commercial issues and condemns the discriminatory treatment against Chinese enterprises [2][3]. - The company has consistently adhered to laws and regulations since acquiring Nexperia, contributing significantly to the European semiconductor industry [5]. Group 2: Financial Performance - Nexperia's revenue peaked at €2.36 billion in 2022, with gross margin increasing from 25% in 2020 to 42.4% in 2022 [8]. - Research and development investment has grown from €112 million in 2019 to €284 million in 2024, with a significant increase in new patent applications [8]. Group 3: Legal and Governance Issues - Some foreign management at Nexperia are attempting to change the company's equity structure through legal means, which is linked to the Dutch government's directive, seen as a political pressure tactic to undermine shareholder rights [10]. - The company is committed to defending its legal rights and has initiated legal and diplomatic actions to demand the withdrawal of the Dutch government's directive and to stop systemic discrimination against Chinese companies [12].
闻泰科技最新声明